Basic Information
| LncRNA/CircRNA Name | LINC00174 |
| Synonyms | NA |
| Region | GRCh38_7:66376044-66493566 |
| Ensemble | ENSG00000179406 |
| Refseq | NR_026873 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qRT-PCR, Western blot |
| Sample | HCC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | LINC00174 is significantly up-regulated in HCC tissues and promotes the malignant phenotypes.LINC00174 functions as a sponge for miR-320, increases the expression level of oncogene S100A10 in HCC. |
| Pubmed ID | 32128852 |
| Year | 2019 |
| Title | LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis |
External Links
| Links for LINC00174 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |